Exabis Library
Welcome to the e-CCO Library!
P644: Leucine-rich alpha 2 glycoprotein- A useful biomarker to discriminate small intestinal mucosal healing in asymptomatic CRP-negative Crohn's disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P644: Mindfulness-based stress reduction in adult patients with active Crohn's disease: preliminary findings based on the subjective units of distress scale: an IIRN study
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P645 Adalimumab drug monitoring is superior to empirical treatment adjustment in inflammatory bowel disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P645: Dynamics of proinflammatory cytokines in patients with Crohn's disease who received combined therapy with mesenchymal stromal cells of bone marrow and azathioprine
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P645: Ileocecal resection in paediatric Crohn’s disease based on the Hungarian Paediatric IBD Registry
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P645: Mental health, work presenteeism and exercise in IBD patients
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P645: Pharmacokinetics and immunogenicity of Infliximab biosimilar in inflammatory bowel disease patients
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P645: The introduction of infliximab therapeutic drug level monitoring for is associated with cost savings in a cohort of patients in a large district general hospital
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P645: Use of Leukocytapheresis in inflammatory bowel disease in paediatric patients. A serie of 10 cases.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P646 Utilisation of indocyanine green fluorescence imaging for Crohn’s disease following intestinal resection
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P646: Histological remission in patients with moderate-to-severe ulcerative colitis undergoing biological therapy: a single-centre experience
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P646: Low FODMAPs diet as a magic bullet in reducing symptoms in different gastrointestinal diseases
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P646: Refinement of surgical technique offsets increased severity of Crohn’s disease and co-morbidities to maintain low post-operative morbidity
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P646: Relative association of bowel urgency clinically meaningful improvement and bowel urgency remission versus stool frequency remission and rectal bleeding remission with improvement in Work Productivity and Activity Impairment Scores in patients with moderately-to-severely active Ulcerative Colitis: An analysis from LUCENT-1 and LUCENT-2 Phase 3 clinical trials.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P646: The Loss of Productivity in Employment and Education Associated to Inflammatory Bowel Diseases: A Pilot Study of the Patient’s Perception
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P646: Will the screening of SARS-COV-2 infection in IBD infusion centers be useful?
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P647 Post-marketing evaluation of reported adverse events of a multi-strain probiotic product confirms that change in manufacturing site had no impact on safety profile
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P647: A pilot study: The importance of cognitive flexibility and flexibility in coping with stress for the quality of life in inflammatory bowel disease patients during biological therapy
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P647: Awareness, knowledge and use of mesenchymal stem cells – a global survey among gastroenterologists and colorectal surgeons
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P647: Idiopathic Thrombocytopenic Purpura associated with Inflammatory Bowel Disease: a multi-centre ECCO CONFER case series
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM